• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

α2-纤溶酶抑制剂在纤维蛋白原中的交联位点。

Cross-linking site in fibrinogen for alpha 2-plasmin inhibitor.

作者信息

Kimura S, Aoki N

出版信息

J Biol Chem. 1986 Nov 25;261(33):15591-5.

PMID:2877981
Abstract

A plasma proteinase inhibitor, alpha 2-plasmin inhibitor (alpha 2PI), is cross-linked with alpha chain of fibrin(ogen) by activated coagulation Factor XIII (plasma transglutaminase). alpha 2PI serves only as a glutamine substrate (amine acceptor) for activated Factor XIII in the cross-linking reaction, and the cross-linking occurs between Gln-2 of the alpha 2PI molecule and a lysine residue (amine donor) of fibrin(ogen) alpha chain, whose position was investigated. alpha 2PI and fibrinogen were reacted by activated Factor XIII. The resulting alpha 2PI fibrinogen A alpha chain complex was separated and subjected to two cycles of Edman degradation using phenyl isothiocyanate for the first cycle and dimethylaminoazobenzene-isothiocyanate for the second cycle. The aqueous phase after the cleavage stage of the second cycle, containing dimethylaminoazobenzene-thiohydantoin-Gln cross-linked with A alpha chain, was subjected to CNBr fragmentation and tryptic digestion. Only one of the peptides was found to have the peak of absorbance at 420 nm, indicating the presence of dimethylaminoazobenzene-thiohydantoin-Gln in that peptide. The peptide was identified as corresponding to residues Asn-290-Arg-348 of A alpha chain by analyses of the NH2-terminal amino acid sequence and amino acid composition. The peptide contains a single lysine at position 303, indicating that Lys-303 of fibrinogen A alpha chain is the lysine residue that forms a cross-link with Gln-2 of alpha 2PI.

摘要

一种血浆蛋白酶抑制剂,α2-纤溶酶抑制剂(α2PI),通过活化的凝血因子 XIII(血浆转谷氨酰胺酶)与纤维蛋白(原)的α链交联。在交联反应中,α2PI仅作为活化因子 XIII 的谷氨酰胺底物(胺受体),交联发生在α2PI分子的Gln-2与纤维蛋白(原)α链的赖氨酸残基(胺供体)之间,对其位置进行了研究。α2PI和纤维蛋白原与活化的因子 XIII 反应。将所得的α2PI-纤维蛋白原Aα链复合物分离,并使用异硫氰酸苯酯进行第一轮埃德曼降解,使用异硫氰酸二甲氨基偶氮苯进行第二轮埃德曼降解,进行两个循环。第二轮裂解阶段后的水相,含有与Aα链交联的二甲基氨基偶氮苯-硫代乙内酰脲-Gln,进行溴化氰裂解和胰蛋白酶消化。仅发现其中一个肽在420nm处有吸光度峰值,表明该肽中存在二甲基氨基偶氮苯-硫代乙内酰脲-Gln。通过对NH2-末端氨基酸序列和氨基酸组成的分析鉴定该肽对应于Aα链的Asn-290-Arg-348残基。该肽在位置303处含有一个赖氨酸,表明纤维蛋白原Aα链的Lys-303是与α2PI的Gln-2形成交联的赖氨酸残基。

相似文献

1
Cross-linking site in fibrinogen for alpha 2-plasmin inhibitor.α2-纤溶酶抑制剂在纤维蛋白原中的交联位点。
J Biol Chem. 1986 Nov 25;261(33):15591-5.
2
Cross-linking of alpha 2-plasmin inhibitor to fibrin catalyzed by activated fibrin-stabilizing factor.由活化的纤维蛋白稳定因子催化的α2-纤溶酶抑制剂与纤维蛋白的交联。
J Biol Chem. 1982 Dec 25;257(24):14767-72.
3
Factor XIII-mediated cross-linking of NH2-terminal peptide of alpha 2-plasmin inhibitor to fibrin.因子 XIII 介导α2-纤溶酶抑制剂氨基末端肽与纤维蛋白的交联。
FEBS Lett. 1983 Mar 21;153(2):369-71. doi: 10.1016/0014-5793(83)80645-0.
4
Release of alpha 2-plasmin inhibitor from plasma fibrin clots by activated coagulation factor XIII. Its effect on fibrinolysis.活化凝血因子XIII促使α2-纤溶酶抑制剂从血浆纤维蛋白凝块中释放。其对纤维蛋白溶解的影响。
J Clin Invest. 1986 Mar;77(3):1006-13. doi: 10.1172/JCI112352.
5
Cross-linking of plasminogen activator inhibitor 2 and alpha 2-antiplasmin to fibrin(ogen).纤溶酶原激活物抑制剂2和α2-抗纤溶酶与纤维蛋白(原)的交联。
J Biol Chem. 2000 Aug 11;275(32):24915-20. doi: 10.1074/jbc.M002901200.
6
Alpha-Chain cross-linking in fibrin(ogen) Marburg.纤维蛋白(原)马尔堡中的α链交联
Blood. 1995 Aug 1;86(3):989-1000.
7
Identification of the alpha chain lysine donor sites involved in factor XIIIa fibrin cross-linking.参与因子XIIIa纤维蛋白交联的α链赖氨酸供体位点的鉴定。
J Biol Chem. 1996 Aug 9;271(32):19288-97. doi: 10.1074/jbc.271.32.19288.
8
Reversible cross-linking of alpha 2-plasmin inhibitor to fibrinogen by fibrin-stabilizing factor.纤维蛋白稳定因子使α2-纤溶酶抑制剂与纤维蛋白原发生可逆性交联。
Biochim Biophys Acta. 1982 Sep 7;706(2):158-64. doi: 10.1016/0167-4838(82)90482-4.
9
Acceleration of fibrinolysis by the N-terminal peptide of alpha 2-plasmin inhibitor.α2-纤溶酶抑制剂N端肽对纤维蛋白溶解的加速作用。
Blood. 1985 Jul;66(1):157-60.
10
Gly-Pro-Arg-Pro modifies the glutamine residues in the alpha- and gamma-chains of fibrinogen: inhibition of transglutaminase cross-linking.甘氨酰-脯氨酰-精氨酰-脯氨酸修饰纤维蛋白原α链和γ链中的谷氨酰胺残基:抑制转谷氨酰胺酶交联。
Biochim Biophys Acta. 1986 Aug 15;872(3):261-8. doi: 10.1016/0167-4838(86)90279-7.

引用本文的文献

1
Acute obstetric coagulopathy is associated with excess plasmin generation and proteolysis of fibrinogen and factor V.急性产科凝血病与纤溶酶生成过多以及纤维蛋白原和凝血因子Ⅴ的蛋白水解有关。
Blood Adv. 2025 Jun 10;9(11):2751-2762. doi: 10.1182/bloodadvances.2024015514.
2
Prevention strategies of postoperative adhesion in soft tissues by applying biomaterials: Based on the mechanisms of occurrence and development of adhesions.基于粘连发生发展机制的软组织术后粘连预防策略:应用生物材料的方法
Bioact Mater. 2023 Mar 17;26:387-412. doi: 10.1016/j.bioactmat.2023.02.026. eCollection 2023 Aug.
3
Plasmin Inhibitor in Health and Diabetes: Role of the Protein as a Therapeutic Target.
健康与糖尿病中的纤溶酶抑制剂:该蛋白作为治疗靶点的作用
TH Open. 2022 Nov 18;6(4):e396-e407. doi: 10.1055/a-1957-6817. eCollection 2022 Oct.
4
Fibrinogen and Antifibrinolytic Proteins: Interactions and Future Therapeutics.纤维蛋白原和抗纤维蛋白溶酶蛋白:相互作用和未来的治疗策略。
Int J Mol Sci. 2021 Nov 21;22(22):12537. doi: 10.3390/ijms222212537.
5
Fibrin(ogen) as a Therapeutic Target: Opportunities and Challenges.纤维蛋白(原)作为治疗靶点:机遇与挑战。
Int J Mol Sci. 2021 Jun 28;22(13):6916. doi: 10.3390/ijms22136916.
6
On the localization of the cleavage site in human alpha-2-antiplasmin, involved in the generation of the non-plasminogen binding form.关于人α-2-抗纤溶酶中裂解位点的定位,该位点参与非纤溶酶原结合形式的产生。
J Thromb Haemost. 2020 May;18(5):1162-1170. doi: 10.1111/jth.14761. Epub 2020 Mar 5.
7
State of the art in factor XIII laboratory assessment.凝血因子 XIII 实验室评估的最新进展。
Transfus Apher Sci. 2018 Dec;57(6):700-704. doi: 10.1016/j.transci.2018.07.006. Epub 2018 Aug 4.
8
The role of β-barrels 1 and 2 in the enzymatic activity of factor XIII A-subunit.β-桶 1 和 2 在因子 XIII A 亚基酶活性中的作用。
J Thromb Haemost. 2018 Jul;16(7):1391-1401. doi: 10.1111/jth.14128. Epub 2018 May 27.
9
Inhibition of Fibrinolysis by Coagulation Factor XIII.凝血因子 XIII 对纤维蛋白溶解的抑制作用。
Biomed Res Int. 2017;2017:1209676. doi: 10.1155/2017/1209676. Epub 2017 Jul 6.
10
Biophysical Mechanisms Mediating Fibrin Fiber Lysis.介导纤维蛋白纤维溶解的生物物理机制。
Biomed Res Int. 2017;2017:2748340. doi: 10.1155/2017/2748340. Epub 2017 May 28.